|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1604 NOK | -2.79% |
|
-0.87% | -42.30% |
BerGenBio ASA reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported sales was NOK 0.774 million compared to NOK 0.601 million a year ago. Net loss was NOK 68.77 million compared to NOK 73.87 million a year ago.
Basic loss per share from continuing operations was NOK 0.78 compared to NOK 0.85 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -42.30% | 58.64M | |
| -1.51% | 104B | |
| +3.22% | 97.42B | |
| +1.02% | 22.2B | |
| -16.53% | 21.23B | |
| -10.28% | 18.33B | |
| -42.33% | 16.35B | |
| -20.09% | 15.06B | |
| +5.47% | 13.98B | |
| +28.85% | 11.66B |
BERGENBIO ASA 
